Discard the vial if it becomes cloudy, discolored, or develops particles
Performance Changes Longer time-to-exhaustion during cardio, improved VO2 max in some users, faster recovery between sessions, and better thermoregulation during exercise
In preclinical research, its been studied for its ability to promote angiogenesis (new blood vessel formation), support collagen organization, and modulate inflammation at the site of injury
PlexusDx recommends working with your healthcare team to establish baseline bloodwork before starting therapy and periodic monitoring at 3, 6, and 12 months
| | 5-Amino-1MQ Monotherapy | None | 50100mg daily | Daily oral or subcutaneous | NNMT inhibition preserves NAD+, activates AMPK and mitochondrial fat oxidation | 812 weeks | Promising preclinical data